These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1352255)

  • 1. Effect of atrial natriuretic peptide on apomorphine-induced stereotyped cage-climbing behavior in mice.
    Bidzseranova A; Gueron J; Tóth G; Penke B; Telegdy G
    Eur J Pharmacol; 1992 Feb; 211(3):411-4. PubMed ID: 1352255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appearance of a stereotyped apomorphine-induced climbing in unresponsive DBA2 mice after subchronic manipulations of brain dopamine transmission.
    Duterte-Boucher D; Costentin J
    Psychopharmacology (Berl); 1989; 98(1):56-60. PubMed ID: 2543019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atrial natriuretic peptide on dopa potentiation in mice.
    Bidzseranova A; Gueron J; Tóth G; Penke B; Telegdy G
    Brain Res Bull; 1992 May; 28(5):767-8. PubMed ID: 1535534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta-/Tyr9/melanotropin-/9-18/ on apomorphine-induced stereotyped cage-climbing and on striatal dopamine release in mice. Comparative studies with amphetamine.
    Vécsei L; Telegdy G; Schally AV; Coy DH
    Neuropeptides; 1982 Dec; 3(2):91-6. PubMed ID: 6891751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of microgram doses of haloperidol on open-field behavior in mice.
    Conceição IM; Frussa-Filho R
    Pharmacol Biochem Behav; 1996 Apr; 53(4):833-8. PubMed ID: 8801585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated low dose apomorphine induced subsensitivity of presynaptic dopamine receptors.
    Masuda Y; Murai S; Saito H; Kohori I; Itoh T
    Pharmacol Biochem Behav; 1987 Sep; 28(1):35-7. PubMed ID: 3659103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of antinociceptive action of morphine by dopamine agonist and antagonist in mice.
    Kamata K; Ogawa K; Kameyama T
    Jpn J Pharmacol; 1985 May; 38(1):113-5. PubMed ID: 4021227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethyl acetate fraction of a methanolic extract of unripe noni (Morinda citrifolia Linn.) fruit exhibits a biphasic effect on the dopaminergic system in mice.
    Pandy V; Narasingam M; Vijeepallam K; Mohan S; Mani V; Mohamed Z
    Exp Anim; 2017 Aug; 66(3):283-291. PubMed ID: 28450692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S; Lai H; Horita A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP; Markovska VL; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permissive role of dopamine in renal action of ANP in volume-expanded rats.
    Katoh T; Sophasan S; Kurokawa K
    Am J Physiol; 1989 Aug; 257(2 Pt 2):F300-9. PubMed ID: 2527470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of yohimbine on dopamine dependent behaviours in rats and mice.
    Bende MM; Bapat TR; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1990 Jul; 34(3):195-200. PubMed ID: 2286423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an involvement of dopamine receptors in the natriuretic response to atrial natriuretic peptide.
    Marin-Grez M; Angchanpen P; Gambaro G; Schnermann J; Schubert G; Briggs JP
    Klin Wochenschr; 1987; 65 Suppl 8():97-102. PubMed ID: 2955166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic activity of ascorbic acid (vitamin C) on dopaminergic modulation: apomorphine-induced stereotypic behavior in mice.
    Deshpande C; Dhir A; Kulkarni SK
    Pharmacology; 2006; 77(1):38-45. PubMed ID: 16569938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopaminergic agents on visceral pain measured by the mouse writhing test.
    Frussa-Filho R; Rocha JB; Conceição IM; Mello CF; Pereira ME
    Arch Int Pharmacodyn Ther; 1996; 331(1):74-93. PubMed ID: 8896712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.